Skip to main content
Clinical Trials/DRKS00032780
DRKS00032780
Recruiting
未知

Implementation of a new treatment scheme for primary hip prosthesis implantations in the German health care system in collaboration with DRV

Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift0 sites70 target enrollmentOctober 4, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Patient with advanced osteoarthritis and indication for endoprosthetic joint replacement of the hip joint (hip TEP)
Sponsor
Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift
Enrollment
70
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 4, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift

Eligibility Criteria

Inclusion Criteria

  • Indication for primary implantation of a total hip joint endoprosthesis
  • \- age: 18 \- 80 years
  • \- Patient is gainfully employed

Exclusion Criteria

  • \- ASA 3\-6
  • \- BMI \> 34 kg/m2
  • \- Diabetes mellitus with blood glucose imbalances (hypoglycemias)
  • \- Chronic renal failure with GFR \< 60 (stage III according to NKF)
  • \- Coronary artery disease with Z.n. intervention within the last 2 years or further complaints
  • \- Permanent anticoagulation with heart valve replacement
  • \- Dementia or other neurological diseases with alteration of gait (Parkinson's syndrome, myasthenia gravis, visual pathway disorders, etc.)
  • \- Anemia / hemophilia / thrombophilia with secondary DVT / LAE
  • \- Known depression / psychoaffective disorder
  • \- Chronic pain patient with long\-term opioid medication

Outcomes

Primary Outcomes

Not specified

Similar Trials